Lyme disease is spreading, but a new vaccine could curb infections
A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal approval and patient uptake could be a challenge
A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal approval and patient uptake could be a challenge
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
